Supplementary report: surveillance of adverse events following immunisation among children aged
Communicable Diseases Intelligence · 01.12.2006 · 30 · 438-442
DOI: 10.33321/cdi.2006.30.42 ↗Kurz gefasst
Fachartikel in der Zeitschrift Communicable Diseases Intelligence, online erschienen am 01.12.2006. Verfasst von Glenda Lawrence und 1 weiteren Autor:innen. Beteiligte Einrichtung: National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, University of Sydney and The Children's Hospital at Westm…. Hauptthemen laut MEDLINE: Adverse Drug Reaction Reporting Systems. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Patientensicherheit, Kinderkrankenpflege
Abstract (Originalsprache)
This report summarises national passive surveillance data collated in the Adverse Drug Reactions Advisory Committee (ADRAC) database at 30 September 2006 for adverse events following immunisation (AEFI) reported for children aged less than 7 years who received vaccines between 1 January and 30 June 2006. It is the first full reporting period for AEFI data following the introduction of a new National Immunisation Program (NIP) schedule, which commenced on 1 November 2005. From that date, varicella vaccine was introduced for children at 18 months of age and inactivated poliovirus vaccines (IPV) replaced oral poliovirus vaccine (OPV) for children at 2, 4 and 6 months and 4 years of age. All children in Australia receive IPV in combined vaccines containing diphtheria-tetanus-acellular pertussis (DTPa) antigens (i.e DTPa-IPV; quadrivalent). In some states and territories, combined vaccines also include hepatitis B (HepB) (i.e. DTPa-IPV-HepB; pentavalent) or both HepB and Haemophilus influenzae type b (Hib) (i.e. DTPa-IPV-HepB-Hib; hexavalent). As a result of these changes, DTPa and DTPa-HepB vaccines are no longer included in the NIP schedule.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, University of Sydney and The Children's Hospital at Westmead, Sydney, Australia. glendal@chw.edu.au
Zitieren
APA
Lawrence, G., & Boyd, I. (2006). Supplementary report: surveillance of adverse events following immunisation among children aged. Communicable Diseases Intelligence, 30, 438-442. https://doi.org/10.33321/cdi.2006.30.42
Vancouver
Lawrence G, Boyd I. Supplementary report: surveillance of adverse events following immunisation among children aged. Communicable Diseases Intelligence. 2006;30:438-442. doi:10.33321/cdi.2006.30.42
BibTeX
@article{Lawrence2006,
author = {Lawrence, Glenda and Boyd, Ian},
title = {Supplementary report: surveillance of adverse events following immunisation among children aged},
journal = {Communicable Diseases Intelligence},
year = {2006},
volume = {30},
pages = {438--442},
doi = {10.33321/cdi.2006.30.42}
}
EUVIMED